MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Assembly Biosciences Inc

Closed

SectorHealthcare

9.23 1.32

Overview

Share price change

24h

Current

Min

8.97

Max

9.71

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+230.14% upside

Dividends

By Dow Jones

Next Earnings

6 May 2025

News Sentiment

By Acuity

50%

50%

180 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Assembly Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 Dec 2024, 15:25 UTC

Major Market Movers

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding

19 Dec 2024, 13:38 UTC

Major Market Movers

Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead

29 Dec 2024, 08:00 UTC

Acquisitions, Mergers, Takeovers

Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com

19 Dec 2024, 13:23 UTC

Major Market Movers

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead

Peer Comparison

Price change

Assembly Biosciences Inc Forecast

Price Target

By TipRanks

230.14% upside

12 Months Forecast

Average 31 USD  230.14%

High 31 USD

Low 31 USD

Based on 2 Wall Street analysts offering 12 month price targets forAssembly Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

N/A / 10.605Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

180 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$